Published in Women's Health Weekly, July 25th, 2002
The randomized multicenter trial coordinated by the departments of gynecology at the Technical University of Munich (TUM) and the Ludwig Maximilians University of Munich (LMU) will be conducted in up to 40 clinical sites across southern Germany under the leadership of Prof. Dr. Marion Kiechle ("Klinikum rechts der Isar," TUM) and Prof. Dr. Harald Sommer (LMU).
The ADEBAR-study (adjuvant docetaxel vs. epirubicin based regimen trial)...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.